Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 31.91

+2.0%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Douglas who wrote (286)	11/10/1997 8:53:00 AM
From: Douglas	Read Replies (1) of 455

Hidden at the very bottom of GILEAD SCIENCES THIRD QUARTER 1997 FINANCIAL RESULTS: Gilead Product PMPA:Commencement of NIH-sponsored Phase I/II trials of topical PMPA for the potential prevention of HIV transmission. Couldn't find any other reference to their topical microbicide. Doug.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next